drugset
drugset / Trial / NCT02459795

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

NCT02459795 ↗

Phase 3 Completed 469 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis.

Timeline

Start
2015-05
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule — —

Indications

actinic keratosis